SSRP1 Activators
SSRP1 activators, as detailed in the list above, include a range of compounds that indirectly influence the activity of SSRP1, a protein integral to chromatin remodeling and transcription regulation. The indirect activation of SSRP1 primarily involves modulation of chromatin structure, histone modifications, and DNA methylation patterns, which in turn can impact the transcriptional regulation activities of SSRP1. Histone deacetylase inhibitors such as Trichostatin A, Vorinostat, Valproic Acid, SAHA, MS-275, and Sodium Butyrate play a pivotal role in modulating chromatin accessibility. These compounds inhibit the deacetylation of histones, leading to a more open chromatin structure that can affect the transcriptional environment in which SSRP1 operates. By altering histone acetylation patterns, these inhibitors enhance SSRP1's ability to interact with chromatin, thereby influencing its role in transcription regulation. DNA methyltransferase inhibitors like 5-Azacytidine change DNA methylation patterns, which can have downstream effects on chromatin structure and gene expression. Such alterations in the epigenetic landscape may affect the transcription and activity of SSRP1, highlighting the intricate connections between DNA methylation, chromatin remodeling, and transcription regulation.
Other compounds, including Caffeine, Nicotinamide, Resveratrol, and Genistein, demonstrate the diverse nature of SSRP1 activators. These compounds, through their various effects on cellular signaling pathways and epigenetic modifications, can indirectly influence the functional dynamics of SSRP1. While the direct impact of these compounds on SSRP1 is not explicitly established, their role in modulating the cellular environment suggests indirect effects on SSRP1 activity. In conclusion, the class of SSRP1 activators comprises a range of chemicals that influence SSRP1 activity indirectly by modulating chromatin dynamics, histone modifications, and DNA methylation. These activators operate through various biochemical pathways, highlighting the complex interplay between epigenetic modifications and transcription regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can indirectly upregulate SSRP1 by altering chromatin structure and DNA methylation patterns, which may affect the transcription and activity of SSRP1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly influences SSRP1 by modifying chromatin accessibility and histone acetylation, potentially affecting SSRP1’s role in chromatin remodeling. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, another histone deacetylase inhibitor, can alter chromatin structure and indirectly modulate SSRP1 activity by changing the transcriptional landscape in which SSRP1 operates. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, also a histone deacetylase inhibitor, can affect chromatin remodeling and indirectly influence SSRP1 function by altering the acetylation status of histones. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275, a specific HDAC inhibitor, may indirectly upregulate SSRP1 by altering chromatin accessibility and acetylation patterns, affecting SSRP1's chromatin-associated functions. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, by modulating various signaling pathways, can indirectly influence cellular processes, including those involving SSRP1, although the exact mechanism of action on SSRP1 is not clearly established. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a short-chain fatty acid and HDAC inhibitor, can indirectly affect SSRP1 activity by altering histone acetylation and chromatin structure. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3 and an HDAC inhibitor, can indirectly modulate SSRP1 activity by changing chromatin dynamics and histone acetylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a natural polyphenol, can influence various signaling pathways and potentially impact SSRP1 activity indirectly, although the direct effects on SSRP1 are not well-defined. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone with kinase inhibitor properties, can indirectly affect SSRP1 function through its impact on various signaling pathways and chromatin structure. | ||||||